BD FACSDiscover™ S8 Cell Sorter enables scientistsin India and across the globe to gain new and more accurate insights on cell populations and characteristics in a streamlined experimental workflow.
India, July 19, 2023: BD (Becton, Dickinson,and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new-to-world cell sorting instrument, the BD FACSDiscover S8. It features two breakthrough technologies namely BD Cell View™ Image Technology and the BD SpectralFX™ Technology,that enable researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments.
“Together, we believe our BD CellView™ Image Technology and BD SpectralFX™ Technology usher in a new era of cell sorting and analysis to enable researchers to answer complex biological questions, such as how cells grow, function and interact, or to study exact locations of viruses or proteins within a cell, at a highly accelerated pace”, said Steve Conly, worldwide president of BD Biosciences. “This technology represents the exciting next chapter in the BD legacy of flow cytometry innovation, and we look forward to now delivering the BD FACSDiscover™ S8 Cell Sorter to customers around the world to empower their novel applications and potentially life-changing discoveries.”
Recognising India’s significance as a crucial market for healthcare research and development, the S8 Cell Sorter will provide immense benefit to research, biopharma, and biotech laboratories worldwide. This advancement has far-reaching applications, significantly disrupting the specialised areas such as gene therapies, cancer immunology, stem cell research, and numerous other domains. By introducing these advancements, the BD FACSDiscover™ S8 Cell Sorter holds the potential to reshape research practices and propel the progress of cell-based therapeutic development.
Commenting on this landmark launch, Puneet Talwar, Business Director- India/ South Asia, BD Lifesciences- Biosciences said, “ BD FACSDiscover S8 is a revolutionary innovation in the field of Flow cytometry. This innovative technology will provide real time imaging and spectral sorting capabilities to Indian scientists which will help them transcend newer boundaries of research. We eagerly look forward to having this exciting product soon in many of the well-known research laboratories of India and the South Asia market.”
The introduction of BD Cell View™ Image Technology will revolutionize cell research in India and around the world, providing researchers with the ability to observe intricate microscopic images of individual cells and promptly validate their findings. By leveraging visual characteristics, researchers can now swiftly sort cells in real time, thereby enhancing their insights.
Additionally, the implementation of BD SpectralFX™ Technology amplifies the cell sorting process by introducing a modular optical architecture and system-aware algorithms. This integration enables high-parameter experiments to be conducted seamlessly, streamlining the workflow. The upgraded flow cytometry innovation from BD, demonstrates another leap forward in the field, ushering in the potential to transform immunology, cell biology and genomics research and the development of cell-based therapies. It also enables researchers to ask and answer an entirely new range of biological questions and perform experiments that were previously impossible.
The BDFACS Discover™S8 Cell Sorter has been featured at the CYTO2023 conference, May2024 in Montréal, and is now available to order globally online and through local sales representatives. More information is available at bdbiosciences.com/S8.
Corporate Comm India (CCI Newswire)
